Indications and uses
for the treatment of acne dries up acne pimples helps prevent new acne pimples
for the treatment of acne dries up acne pimples helps prevent new acne pimples
Cleanse the entire affected area with a thin layer and rinse thoroughly one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Store away from heat and direct sunlight. Store at controlled room temperature: 15°C–25°C (59°F– 77°F).
Drug Facts
Salicylic Acid 2%
Acne treatment
For external use only
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Benzyl Benzoate, BHT, Dicaprylyl Ether, Dimethyl Isosorbide, Disodium EDTA, Hydroxyethyl Acrylate/ Sodium Acryloyldimethyl Taurate Copolymer, Phenoxyethanol, Polysorbate 60, Propylene Glycol, Squalane, Water (Aqua)
1.800.636.7546
Monday–Friday 9a.m.–4p.m. Pacific Time
Drug Facts
Salicylic acid 2%
Acne treatment
For external use only
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
benzyl alcohol, chamomilla recutita (matricaria) flower extract, ethoxydiglycol, ext. violet 2, fragrance, glycerin, menthol, menthoxypropanediol, menthyl lactate, SD alcohol 40-B, water (aqua)
1.800.636.7546
Monday–Friday 9a.m.–4p.m. Pacific Time
Drug Facts
Benzoyl peroxide 5%
Acne treatment
For external use only
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
benzyl benzoate, BHT, dicaprylyl ether, dimethyl isosorbide, disodium EDTA, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, phenoxyethanol, polysorbate 60, propylene glycol, squalane, water (aqua)
1.800.636.7546
Monday–Friday 9a.m.–4p.m. Pacific Time
Distributed by Obagi Cosmeceuticals LLC,
Long Beach, CA 90806
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2191891 | {1 (47 ML) (benzoyl peroxide 50 MG/ML Topical Lotion) / 1 (118 ML) (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (148 ML) (salicylic acid 20 MG/ML Topical Solution) } Pack | GPCK | 3 |
| 106309 | benzoyl peroxide 5 % Topical Lotion | PSN | 3 |
| 1236624 | Clenziderm Lotion 5 % Topical Lotion | PSN | 3 |
| 1235205 | CLENZIderm M.D. 2 % Medicated Liquid Soap | PSN | 3 |
| 1235208 | CLENZIderm M.D. 2 % Pore Therapy Topical Solution | PSN | 3 |
| 562600 | salicylic acid 2 % Medicated Liquid Soap | PSN | 3 |
| 251577 | salicylic acid 2 % Topical Solution | PSN | 3 |
| 2191891 | salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack | PSN | 3 |
| 1236624 | benzoyl peroxide 50 MG/ML Topical Lotion [Clenziderm Lotion] | SBD | 3 |
| 1235205 | salicylic acid 20 MG/ML Medicated Liquid Soap [Clenziderm] | SBD | 3 |
| 1235208 | salicylic acid 20 MG/ML Topical Solution [Clenziderm] | SBD | 3 |
| 106309 | benzoyl peroxide 50 MG/ML Topical Lotion | SCD | 3 |
| 562600 | salicylic acid 20 MG/ML Medicated Liquid Soap | SCD | 3 |
| 251577 | salicylic acid 20 MG/ML Topical Solution | SCD | 3 |
| 106309 | benzoyl peroxide 5 % Topical Lotion | SY | 3 |
| 1235205 | Clenziderm 20 MG/ML Medicated Liquid Soap | SY | 3 |
| 1235208 | Clenziderm 20 MG/ML Topical Solution | SY | 3 |
| 1236624 | Clenziderm Lotion 5 % Topical Lotion | SY | 3 |
| 1236624 | Clenziderm Lotion 50 MG/ML Topical Lotion | SY | 3 |
| 1235205 | Clenziderm M.D. 2 % Daily Care Cleanser | SY | 3 |
| 1235208 | Clenziderm M.D. 2 % Pore Therapy | SY | 3 |
| 562600 | salicylic acid 2 % Facial Cleanser Toner | SY | 3 |
| 562600 | salicylic acid 2 % Facial Scrub | SY | 3 |
| 562600 | salicylic acid 2 % Medicated Liquid Soap | SY | 3 |
| 251577 | salicylic acid 2 % Topical Solution | SY | 3 |
| 2191891 | salicylic acid 2 % Topical Solution (148 ML) / benzoyl peroxide 5 % MG/ML Topical Lotion (47 ML) / salicylic acid 2 % Medicated Liquid Soap (118 ML) Pack | SY | 3 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a46239a7-5963-4008-8cbb-6b9000f497eb | Product name | 1 | 20250721 |
| b382b4e1-6b48-45f6-bffc-e61b00b0ce19 | Product name | 3 | 20250317 |
| d9d61457-6a5a-41fc-b418-e5479a2904b7 | Product name | 2 | 20230303 |
| 32012d5c-25ac-49c7-9d4c-1313177fff7c | Product name | 1 | 20230112 |
| 13e7e7e3-e885-4c79-af6d-dad1aedbb06e | Product name | 1 | 20220128 |
| 4a7d44fe-774d-404b-aad0-8a90fe78375a | Product name | 4 | 20211025 |
| 3f45980c-c196-47e5-0e5e-48b7c57327c5 | Product name | 5 | 20200428 |
| d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27b | Product name | 3 | 20200203 |
| ee5c6de5-d9cd-454f-b250-7b19e5cf2992 | Product name | 4 | 20190619 |
| ad75fcfd-a339-42a1-9c60-43ba2c654cfa | Product name | 1 | 20170810 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62032-613-01 | 2025-03-19 | C162847 | 48780-1 | 2cef2736-8c59-d83d-e063-dadaa90ab31f | CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM |
| 62032-613-09 | 2025-03-19 | C162847 | 48780-1 | 2cef2736-8c59-d83d-e063-dadaa90ab31f | CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM |
| 62032-613-15 | 2025-03-19 | C162847 | 48780-1 | 2cef2736-8c59-d83d-e063-dadaa90ab31f | CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM |
| 62032-613-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8c59-d83d-e063-dadaa90ab31f | CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM |
| 62032-613-09 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8c59-d83d-e063-dadaa90ab31f | CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM |
| 62032-613-15 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8c59-d83d-e063-dadaa90ab31f | CLENZIDERM M.D.™ SYSTEM ACNE THERAPEUTIC SYSTEM |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62032-610-11 | clenziderm m.d. systemacne therapeutic system | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 mL | 20 mg in 1mL | 3 |
| 62032-611-01 | clenziderm m.d. systemacne therapeutic system | 47 mL in 1 BOTTLE, PLASTIC | LOTION | 47 mL | 50 mg in 1mL | 3 |
| 62032-612-04 | clenziderm m.d. systemacne therapeutic system | 148 mL in 1 BOTTLE, PLASTIC | LIQUID | 148 mL | 20 mg in 1mL | 3 |
| 62032-613-01 | clenziderm m.d. systemacne therapeutic system | 1 in 1 CARTON | KIT | 1 | 3 | |
| 62032-613-09 | clenziderm m.d. systemacne therapeutic system | 1 in 1 CARTON | KIT | 1 | 3 | |
| 62032-613-15 | clenziderm m.d. systemacne therapeutic system | 1 in 1 CARTON | KIT | 1 | 3 | |
| 62032-613-15 | clenziderm m.d. systemacne therapeutic system | 1 in 1 BAG | KIT | 1 | 3 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62032-610 | CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC | 20250322_7710e51a-dd3a-4f44-8c97-c089c6817cb0.zip |
| 62032-611 | CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC | 20250322_7710e51a-dd3a-4f44-8c97-c089c6817cb0.zip |
| 62032-612 | CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC | 20250322_7710e51a-dd3a-4f44-8c97-c089c6817cb0.zip |
| 62032-613 | CLENZIDERM M.D. SYSTEM ACNE THERAPEUTIC SYSTEM (SALICYLIC ACID AND BENZOYL PEROXIDE) KIT [OBAGI COSMECEUTICALS LLC] | 3 | Current NDC, Legacy NDC, 7 package rows | 20250322_7710e51a-dd3a-4f44-8c97-c089c6817cb0.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62032-613 | 62032-613-01, 62032-613-09, 62032-613-15 |
| 62032-610 | 62032-610-11 |
| 62032-612 | 62032-612-04 |
| 62032-611 | 62032-611-01 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.